June 2017 Vol 8, No 6
I’ve just returned from our West Coast Regional Meeting, where attendees enjoyed a robust agenda featuring speakers from across the oncology community. I cannot help but feel re-energized in our mission to advance the cause of navigation!
Tara Albrecht, PhD, ACNP-BC, RN, Justin E. Bala-Hampton, DNP, MPH, RN, AGACNP-BC, Linda Dudjak, PhD, RN, Margaret Q. Rosenzweig, PhD, FNP-C, AOCN, FAAN
The authors explore the concept of perceived economic hardship and economic distress among a cohort of adult patients at least 6 months postdiagnosis of AML.
In this latest installment of the Evidence into Practice series, Ms. Bellomo discusses the responsibilities of navigators as they relate to the guiding principles of navigation to include quality, confidentiality, and professionalism.
Eugenia Artice, RN-BC, BSN, Marian E. Gilmore, RN, OCN, Pamela Goetz, BA, OPN-CG, Barbara R. McHale, RN, BS, OCN, CBCN, ONN-CG
The authors present a case demonstrating the responsibilities of the navigator on the multidisciplinary team to include ensuring timeliness of care, care coordination, addressing barriers to care, program evaluation, and process improvement.
A case showing how navigation is integral to facilitate effective interprofessional collaboration and promote patient satisfaction and quality of care, as well as the efficient use of healthcare resources.
Adding Cisplatin to Standard Regimen Leads to Unprecedented Response Rate in Patients with Stage IV Pancreatic Cancer
The addition of cisplatin to standard therapy with gemcitabine and nab-paclitaxel was associated with a median overall survival that “has not been seen in stage IV pancreatic cancer,” according to Gayle Jameson, MSN, ACNP-BC, Nurse Practitioner Investigator of Clinical Trials, HonorHealth Research Institute, Scottsdale, AZ.
Tricia Strusowski recently gave a presentation on the AONN+ Standardized Metrics to a captivated audience at the Association of Community Cancer Centers.
Results 1 - 7 of 7